Oxygen Therapy News and Research

RSS
Oxygen therapy is the administration of oxygen as a medical intervention, which can be for a variety of purposes in both chronic and acute patient care.
Cognitive decline persists in older adults long after severe COVID-19 recovery

Cognitive decline persists in older adults long after severe COVID-19 recovery

Iron dysregulation identified as potential trigger for long COVID

Iron dysregulation identified as potential trigger for long COVID

Investigating dosage in hyperbaric oxygen therapy for post-covid conditions

Investigating dosage in hyperbaric oxygen therapy for post-covid conditions

Study reveals limited access to pulmonary rehabilitation for millions of Americans

Study reveals limited access to pulmonary rehabilitation for millions of Americans

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

Mount Sinai secures $6.2 million grant to expand the Cohen Center for Recovery From Complex Chronic Illnesses

Mount Sinai secures $6.2 million grant to expand the Cohen Center for Recovery From Complex Chronic Illnesses

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

Study finds impaired beta cell function associated with severe COVID-19-induced hyperglycemia

Study finds impaired beta cell function associated with severe COVID-19-induced hyperglycemia

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Critically ill corona patients benefit from COVID-19 vaccination

Critically ill corona patients benefit from COVID-19 vaccination

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

VR training shown to be as effective as inpatient training for nursing students

VR training shown to be as effective as inpatient training for nursing students

Penn researchers discover new type of cell that may play key role in human lung diseases

Penn researchers discover new type of cell that may play key role in human lung diseases

Individuals with autosomal and X-linked recessive deficiency of IRAK-4 and MyD88 are more susceptible to developing hypoxemic COVID-19 pneumonia

Individuals with autosomal and X-linked recessive deficiency of IRAK-4 and MyD88 are more susceptible to developing hypoxemic COVID-19 pneumonia

Specific group of COVID-19 patients benefits the most from remdesivir, new analysis shows

Specific group of COVID-19 patients benefits the most from remdesivir, new analysis shows

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.